A viral ChatGPT prompt plans your week backwards, starting from Friday's results. Here is how it works and the prompt to ...

Pete Crow-Armstrong entered Monday night's contest against the Colorado Rockies already on a tear at the plate, but the Chicago Cubs center fielder took things to a truly historic level in what turned ...

⚾ Seattle Mariners catcher Cal Raleigh will be activated off the 10-day injured list today. He has been sidelined with a strained right oblique. ⚾ Houston Astros right-handed starter Hunter Brown will ...

CHICAGO, June 11, 2026 (GLOBE NEWSWIRE) -- Verano Holdings Corp. (Cboe CA: VRNO) (OTCQX: VRNO) (“Verano” or the “Company”), a leading multi-state cannabis company, today announced that the 1-for-5 ...

Over the last six months, pressure has mounted on Oklo (NYSE: OKLO), with shares dropping 44% as of this writing. The company keeps burning cash, and with no meaningful revenue, there hasn't been much ...

Oklo stock has been in a slump for the last six months. A recent announcement helped the stock price jump higher. For a sustained rally, however, more is needed. 10 stocks we like better than Oklo › ...

Wilmington, DE – DuPont announced that its Board of Directors has approved a reverse stock split of the Company’s common stock, par value $0.01 per share, at a ratio of 1-for-3 as well as a reduction ...

Life Biosciences says it just dosed its first patient in an FDA-approved clinical trial to reverse age-related blindness. Reading time 3 minutes Buckle up. High-stakes human testing has now begun on a ...

Megan Cerullo is a New York-based reporter for CBS MoneyWatch covering small business, workplace, health care, consumer spending and personal finance topics. She regularly appears on CBS News 24/7 to ...

A longevity startup has dosed its first patient with a drug to reverse age-related sight loss. Life Biosciences is testing its ER-100 drug, which the company claims has restored vision in monkeys, for ...